# US 2020/0263207 A1 · Enzyme blends and processes for improving the nutritional quality of animal feed

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2020/0263207 A1
- Document ID: US20200263207A1
- Status: Published application
- Kind: A1
- Application number: 16/646,709
- Filed: 2018-09-12
- Published: 2020-08-20
- Earliest claimed: 2017-09-15
- Assignees: Novozymes A/S
- Applicants: Novozymes A/S
- Inventors: Jesper FRICKMANN; Kendra STALLINGS; Dan PETTERSSON; Mads Brøgger PEDERSEN; Harold Cale SMITH
- Web page: https://patentgrep.com/patent/US20200263207A1

## CPC

- C12P 7/06: Ethanol, i.e. non-beverage
- C12P 19/02: Monosaccharides (2-ketogulonic acid C12P7/60)
- C12P 19/14: produced by the action of a carbohydrase {(EC 3.2.x)}, e.g. by alpha-amylase {, e.g. by cellulase, hemicellulase}
- C12Y 302/01004: Cellulase (3.2.1.4), i.e. endo-1,4-beta-glucanase
- C12Y 302/01091: Cellulose 1,4-beta-cellobiosidase (3.2.1.91)
- C12Y 302/01136: Glucuronoarabinoxylan endo-1,4-beta-xylanase (3.2.1.136), i.e. feraxanase or feraxan-endoxylanase
- Y02E 50/10: Biofuels, e.g. bio-diesel
- C12P: FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE {(brewing of beer C12C; producing vinegar C12J; producing specific peptides or proteins C07K; producing enzymes C12N9/00; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification C12N15/00; measuring or testing processes involving enzymes or microorganisms C12Q; measuring or testing processes involving nucleic acid amplification reactions C12Q1/6844; fermentation processes to form a food composition, A21 or A23; compounds in general, see the relevant compound class, e.g. C01, C07)}
- C12Y: ENZYMES
- Y02E: REDUCTION OF GREENHOUSE GAS [GHG] EMISSIONS, RELATED TO ENERGY GENERATION, TRANSMISSION OR DISTRIBUTION

## Abstract

The present invention relates to a process for improving the nutritional quality of distillers dried grains (DGS) or distillers dried grains with solubles (DDGS) produced as a co-product of a fermentation product production process, processes for producing fermentation products, as well as enzyme blends used in the processes.

## Claims

### Claim 1

A process of producing a fermentation product, comprising the following steps:
(a) saccharifying a starch-containing material at a temperature below the initial gelatinization temperature with an alpha-amylase, a glucoamylase, and a xylanase or an enzyme blend comprising the xylanase;
(b) fermenting using a fermentation organism to produce the fermentation product; and
(c) optionally recovering a co-product.

### Claim 2

A process for producing a fermentation product from starch-containing material comprising the steps of:
(a) liquefying a starch-containing material with an alpha-amylase;
(b) saccharifying the liquefied material obtained in step (a) with a glucoamylase and a xylanase or enzyme blend comprising the xylanase;
(c) fermenting using a fermenting organism; and
(d) optionally recovering a co-product.

### Claim 3 (depends on 1)

The process of claim 1, wherein saccharification and fermentation is performed simultaneously.

### Claim 4 (depends on 2)

The process of claim 2, wherein the starch-containing material comprises maize, corn, wheat, rye, barley, triticale, sorghum, switchgrass, millet, pearl millet, foxtail millet.

### Claim 5 (depends on 2)

The process of claim 2, wherein the fermentation product is ethanol.

### Claim 6 (depends on 2)

The process of claim 2, wherein the co-product is distillers dried grains (DDG) or distillers dried grains with solubles (DDGS).

### Claim 7 (depends on 2)

The process of claim 2, wherein the DDG or DDGS have an improved nutritional quality compared to DDG or DDGS recovered as a co-product of a process for producing a fermentation product in which the xylanase or enzyme blend comprising the xylanase is not present or added.

### Claim 8 (depends on 7)

The process of claim 7, wherein the DDG or DDGS have increased fat content.

### Claim 9 (depends on 2)

The process of claim 2, wherein the true metabolizable energy of the DGS or DDGS is increased by at least 5% as compared to the TME of DGS or DDGS produced when a xylanase or enzyme blend comprising a xylanase is not present during the saccharification step, fermentation step, and/or simultaneous saccharification and fermentation step of the process.

### Claim 10 (depends on 9)

The process according to claim 9, wherein the TME is for a monogastric animal.

### Claim 11 (depends on 9)

The process according to claim 9, wherein the DGS or DDGS produced are not darkened after drying as compared to DGS or DDGS produced when the xylanase or enzyme blend comprising the xylanase is not present during the saccharification step, fermentation step, and/or simultaneous saccharification and fermentation step.

### Claim 12 (depends on 2)

The process of claim 2, wherein the fermenting organism is yeast.

### Claim 13 (depends on 2)

The process of claim 2 wherein the enzyme blend further comprises a cellulolytic composition.

### Claim 14 (depends on 13)

The process of claim 13, wherein the cellulolytic composition is present in the blend in a ratio of xylanase and cellulolytic composition from about 5:95 to about 95:5.

### Claim 15 (depends on 2)

The process of claim 2, wherein the xylanase is a GH30 family xylanase.

### Claim 16 (depends on 2)

The process of claim 2, wherein the xylanase is a GH30_8 xylanase.

### Claim 17 (depends on 2)

The process of claim 2, wherein the xylanase is a GH30_8 xylanase selected from the group consisting of:
(i) the Bacillus subtilis xylanase of SEQ ID NO: 1 or a variant thereof having at least 80%, at least 85%, at least 90%, at least 95%, at least 96%, at least 97%, at least 98%, or at least 99% amino acid sequence identity thereto;
(ii) the Bacillus subtilis xylanase of SEQ ID NO: 2 or a variant thereof having at least 80%, at least 85%, at least 90%, at least 95%, at least 96%, at least 97%, at least 98%, or at least 99% amino acid sequence identity thereto;
(iii) the Bacillus subtilis xylanase of SEQ ID NO: 3 or a variant thereof having at least 80%, at least 85%, at least 90%, at least 95%, at least 96%, at least 97%, at least 98%, or at least 99% amino acid sequence identity thereto;
(iv) the Bacillus amyloliquefaciens xylanase of SEQ ID NO: 4 or a variant thereof having at least 80%, at least 85%, at least 90%, at least 95%, at least 96%, at least 97%, at least 98%, or at least 99% amino acid sequence identity thereto;
(v) the Bacillus amyloliquefaciens xylanase of SEQ ID NO: 5 or a variant thereof having at least 80%, at least 85%, at least 90%, at least 95%, at least 96%, at least 97%, at least 98%, or at least 99% amino acid sequence identity thereto;
(vi) the Bacillus licheniformis xylanase of SEQ ID NO: 6 or a variant thereof having at least 80%, at least 85%, at least 90%, at least 95%, at least 96%, at least 97%, at least 98%, or at least 99% amino acid sequence identity thereto; and
(vii) the Paenibacillus pabuli xylanase of SEQ ID NO: 2 or a variant thereof having at least 80%, at least 85%, at least 90%, at least 95%, at least 96%, at least 97%, at least 98%, or at least 99% amino acid sequence identity thereto.

### Claim 18 (depends on 13)

The process of claim 13, wherein the cellulolytic composition comprises at least one, at least two, at least three, or at least four enzymes selected from the group consisting of:
(i) a cellobiohydrolase I;
(ii) a cellobiohydrolase II;
(iii) a beta-glucosidase; and
(iv) a GH61 polypeptide having cellulolytic enhancing activity.

### Claim 19

(canceled)

### Claim 20 (depends on 13)

The process of claim 13, wherein the cellulolytic composition comprises:
(i) a cellobiohydrolase I comprising amino acids 27 to 532 of SEQ ID NO: 8 or a variant thereof having at least 80%, at least 85%, at least 90%, at least 95%, at least 96%, at least 97%, at least 98%, or at least 99% sequence identity to amino acids 27 to 532 of SEQ ID NO: 8;
(ii) a cellobiohydrolase II comprising amino acids 20 to 454 of SEQ ID NO: 9 or a variant thereof having at least 80%, at least 85%, at least 90%, at least 95%, at least 96%, at least 97%, at least 98%, or at least 99% sequence identity to amino acids 20 to 454 of SEQ ID NO: 9;
(iii) a beta-glucosidase comprising amino acids 20 to 863 of SEQ ID NO: 10 or a variant thereof having at least one substitution selected from the group consisting of F100D, S283G, N456E, and F512Y and at least 80%, at least 85%, at least 90%, at least 95%, at least 96%, at least 97%, at least 98%, or at least 99% sequence identity to amino acids 20 to 863 of SEQ ID NO: 10; and/or
(iv) a GH61A polypeptide having cellulolytic enhancing activity comprising amino acids 26 to 253 of SEQ ID NO: 11 or a variant thereof having at least 80%, at least 85%, at least 90%, at least 95%, at least 96%, at least 97%, at least 98%, or at least 99% sequence identity to amino acids 26 to 253 of SEQ ID NO: 11.

### Claim 21 (depends on 13)

The process of claim 13, wherein the cellulolytic composition further comprises an endoglucanase.

### Claim 22

(canceled)

### Claim 23

(canceled)

### Claim 24

(canceled)

### Claim 25

(canceled)
